WuXi PharmaTech Cayman Inc

Type: Company
Name: WuXi PharmaTech Cayman Inc (WuXi PharmaTech (Cayman) Inc)
First reported Jul 22 2014 - Updated Jul 22 2014 - 4 reports

WuXi PharmaTech Schedules Second-Quarter 2014 Earnings Release

Following the earnings announcement, senior management will host a conference call at 8:00 amA telephone replay will be available two hours after the call's completion at:A live webcast of the conference call and replay will be available in the investor ... [Published Pettinga Financial Advisors - Jul 22 2014]
First reported Jul 16 2014 - Updated Jul 16 2014 - 1 reports

Muddy Waters Oops: Looks Like Short Sellers Missed The Mark On NQ Mobile Again

, Muddy Waters highly suggested that Ms. Han stepped down at NQ Mobile due to problems (fraud concerns). Ms. Han's recent departure from Wuxi PharmaTech (citing personal reasons), shows that she did not step down from NQ Mobile over "fraud concerns". ... [Published Seeking Alpha - Jul 16 2014]
First reported Jul 14 2014 - Updated Jul 14 2014 - 1 reports

China's HD Bio teams with Marshall U. for cancer R

Chinese clinical research outfit HD Biosciences has struck a deal with Marshall University to collaborate on cancer drug development, sharing costs and risks in hopes of commercializing new therapies.Under the deal, the Shanghai-headquartered HD will ... [Published Fierce CRO - Jul 14 2014]
Entities: Cancer, Drugs, China
First reported Jul 14 2014 - Updated Jul 14 2014 - 1 reports

Scheduled Conference Calls and Managements Changes - Analyst Notes on Spectranetics, Charles River, Chemed, WuXi PharmaTech and Ironwood Pharmaceuticals

PR NewswireNEW YORK, July 14, 2014NEW YORKToday, Analysts Review released its analysts' notes regarding The Spectranetics Corporation (NASDAQ: SPNC), Charles River Laboratories (NYSE: CRL), Chemed Corporation (NYSE: CHE), WuXi PharmaTech (Cayman) Inc. ... [Published Digital Journal - Jul 14 2014]
First reported Jul 14 2014 - Updated Jul 14 2014 - 2 reports

WuXi PharmaTech announces resignation of board member

WuXi PharmaTech Cayman Inc., a pharmaceutical, biotechnology and medical device R&D services company, has announced the resignation of Ying Han from the board of directors. Ms Han has served on WuXi's board since 2008. WuXi has begun a search for a new ... [Published Individual.com - Jul 14 2014]
First reported Jul 09 2014 - Updated Jul 09 2014 - 1 reports

NQ Mobile: Jumping To Conclusions, The Muddy Waters Board Game

Summary Muddy Waters jumped to conclusions and missed, yet again. Ms. Ying Han resigned as Audit Chair for both WuXi PharmaTech and NQ Mobile for validated personal reasons. There were no disagreements between her and NQ Mobile. It's highly unlikely ... [Published Seeking Alpha - Jul 09 2014]
First reported Jul 08 2014 - Updated Jul 09 2014 - 4 reports

WuXi PharmaTech board member steps down

Singapore : Ms Ying Han, member of board of WuXi PharmaTech, has stepped down from the company.WuXi PharmaTech is China based global contract R&D services provider serving the pharmaceutical, biotech, and medical device industries.Ms Han has served on ... [Published Bio Spectrum Asia - Jul 09 2014]
First reported Jul 09 2014 - Updated Jul 09 2014 - 1 reports

Hottest Healthcare Stocks Now – TARO OMI ESC AGN

Popular Posts: Recent Posts: Healthcare stocks finished down 0.9% on Wall Street today.More broadly, the Dow Jones Industrial Average fell 0.6%, the Nasdaq was down 1.2% and the S&P 500 declined 0.6%.Some of the biggest gainers among healthcare stocks ... [Published InvestorPlace.com - Jul 09 2014]
Entities: Stocks, Healthcare, Podd
First reported Jul 01 2014 - Updated Jul 01 2014 - 1 reports

5 Foreign Stocks You Need to Sell This Summer

BALTIMORE (Stockpickr) -- "U-S-A! U-S-A! U-S-A!" >>5 Rocket Stocks to Trade in JulySoccer fans across the country are getting ready to root for the U.S. men's national soccer team for the World Cup match this evening. What you might not realize ... [Published The Street Latest - Jul 01 2014]
First reported Jun 20 2014 - Updated Jun 20 2014 - 6 reports

Wuxi Pharmatech (Cayman) Inc's toxicology facility in Suzhou passes FDA inspection

Wuxi Pharmatech (Cayman) Inc:Says its toxicology facility in Suzhou recently passed surveillance Good Laboratory Practice (GLP) inspection by the U.S. Food and Drug Administration (FDA) with no major observations.This was the first FDA GLP inspection ... [Published Reuters - Jun 20 2014]
First reported May 12 2014 - Updated May 13 2014 - 2 reports

WuXi PharmaTech Completes Construction of New Biosafety Testing Facility in Suzhou

SHANGHAI, May 13, 2014 /PRNewswire/ -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading pharmaceutical, biotechnology, and medical device R&D services company with operations in China and the United States, today announced that construction has been ... [Published PR Newswire: General Business - May 13 2014]
First reported Apr 07 2014 - Updated Apr 08 2014 - 2 reports

CORRECTION - WuXi PharmaTech Receives Honorable Mention at 2014 ISPE Facility of the Year Awards

SHANGHAI, April 8, 2014 /PRNewswire/ -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading pharmaceutical, biotechnology, and medical device R&D services company with operations in China and the United States, today announced that it has received an ... [Published PR Newswire: General Business - Apr 08 2014]

Quotes

"... Ms. Ying Han, the current Chair of the Audit Committee has informed the Board that she would be stepping down from the Board due to personal reasons not related to her role at the Company effective on July 6, 2014. There are no disagreements between Ms. Han in her capacity as Chair of the Audit Committee and the Company. "
...the technology MIIR and the school of medicine have developed over the last several years into viable drug candidates," Xie said in statement. "This joint effort with HD Biosciences will significantly shorten the process because of their expertise in drug discovery, and ultimately will reduce the risk for all the partners."
Dr Ge Li, Chairman and CEO of WuXi PharmaTech, commented, "On behalf of the board, I want to thank Ying for her many years of excellent service as a WuXi board member. All of us at WuXi wish her the very best."
and that "NQ deliberately held back both (PWC expansion of audit scope) admissions so that NQ China insiders and their proxies could illegally dump more shares at existing shareholders' expense"

More Content

All (78) | News (39) | Reports (0) | Blogs (27) | Audio/Video (0) | Fact Sheets (2) | Press Releases (10)
sort by: Date | Relevance
WuXi PharmaTech Schedules Second-Quarter 2014 E... [Published Pettinga Financial Advisors - Jul 22 2014]
WuXi PharmaTech Schedules Second-Quarter 2014 E... [Published Individual.com - Jul 22 2014]
WuXi PharmaTech Schedules Second-Quarter 2014 E... [Published Nasdaq - Jul 22 2014]
WuXi PharmaTech Schedules Second-Quarter 2014 E... [Published PR Newswire: Health - Jul 22 2014]
Research Analysts’ Upgrades for July, 16th (ACA... [Published American Banking News - Jul 16 2014]
Muddy Waters Oops: Looks Like Short Sellers Mis... [Published Seeking Alpha - Jul 16 2014]
China's HD Bio teams with Marshall U. for cancer R [Published Fierce CRO - Jul 14 2014]
Scheduled Conference Calls and Managements Chan... [Published Digital Journal - Jul 14 2014]
Scheduled Conference Calls and Managements Chan... [Published Financial Services - Jul 14 2014]
WuXi PharmaTech announces resignation of board ... [Published Individual.com - Jul 14 2014]
WuXi PharmaTech: Ying Han Resigns from Board [Published Individual.com - Jul 14 2014]
NQ Mobile: Jumping To Conclusions, The Muddy Wa... [Published Seeking Alpha - Jul 09 2014]
Philip Ehrmann: new opportunism in the China story [Published Money Marketing Online - Jul 09 2014]
WuXi PharmaTech board member steps down [Published Bio Spectrum Asia - Jul 09 2014]
Hottest Healthcare Stocks Now – TARO OMI ESC AGN [Published InvestorPlace.com - Jul 09 2014]
Director Ying Han Resigns from WuXi Board [Published Industrial Info Financials - Jul 08 2014]
Director Ying Han Resigns from WuXi Board [Published BusinessWeek - Jul 08 2014]
Director Ying Han Resigns from WuXi Board [Published PR Newswire: General Business - Jul 08 2014]
NQ Mobile: Oops [Published Seeking Alpha - Jul 07 2014]
WuXi PharmaTech Cayman Shares Climbing Higher, ... [Published Individual.com - Jul 03 2014]
Biggest Movers in Healthcare Stocks Now – GPRO ... [Published InvestorPlace.com - Jul 03 2014]
5 Foreign Stocks You Need to Sell This Summer [Published The Street Latest - Jul 01 2014]
Biggest Movers in Healthcare Stocks Now – TARO ... [Published InvestorPlace.com - Jun 27 2014]
Biggest Movers in Healthcare Stocks Now – PBYI ... [Published InvestorPlace.com - Jun 26 2014]
Collaborations, Clinical Study Results, and Lab... [Published Financial Services - Jun 25 2014]
WuXi's Suzhou facility clears FDA inspection [Published Bio Spectrum Asia - Jun 23 2014]
Wuxi Pharmatech (Cayman) Inc's toxicology facil... [Published Reuters - Jun 20 2014]
WuXi PharmaTech Toxicology Facility in Suzhou P... [Published WFMJ 21 - TV - Jun 20 2014]
WuXi Facility In Suzhou Passes FDA Inspection -... [Published RTTNews.com - Jun 20 2014]
WuXi PharmaTech Toxicology Facility in Suzhou P... [Published Barchart - Jun 20 2014]
1 2 3
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
WuXi PharmaTech Schedules Second-Quarter 2014 E... [Published PR Newswire: Health - Jul 22 2014]
SHANGHAI, July 22, 2014 /PRNewswire/ -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading pharmaceutical, biotechnology and medical device R&D outsourcing company with operations in China and the United States, today announced that it will release financial ...
Director Ying Han Resigns from WuXi Board [Published PR Newswire: General Business - Jul 08 2014]
SHANGHAI, July 8, 2014 /PRNewswire/ -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading pharmaceutical, biotechnology, and medical device R&D services company with operations in China and the United States, today announced that Ying Han has stepped ...
WuXi PharmaTech Toxicology Facility in Suzhou P... [Published PR Newswire: Policy & Public Interest - Jun 20 2014]
SHANGHAI, June 20, 2014 /PRNewswire/ -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading pharmaceutical, biotechnology, and medical device R&D services company with operations in China and the United States, today announced that its toxicology facility ...
WuXi PharmaTech Begins Operation of New High-Po... [Published PR Newswire: Health - May 28 2014]
SHANGHAI, May 28, 2014 /PRNewswire/ -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX), a leading pharmaceutical, biotechnology, and medical device R&D services company with operations in China and the United States, today announced that its manufacturing subsidiary, ...
WuXi PharmaTech Toxicology Facility in Suzhou P... [Published PR Newswire: Health - May 21 2014]
SHANGHAI, May 21, 2014 /PRNewswire/ -- WuXi PharmaTech (NYSE: WX) today announced that its toxicology facility in Suzhou had received a statement of Good Laboratory Practice (GLP) from the Belgium Scientific Institute of Public Health on behalf of the ...
1 2 3 4 5 6

Press Releases

sort by: Date | Relevance
Scheduled Conference Calls and Managements Chan... [Published Financial Services - Jul 14 2014]
Collaborations, Clinical Study Results, and Lab... [Published Financial Services - Jun 25 2014]
Health Care Sector Stocks Coverage -- Research ... [Published Financial Services - Jun 18 2014]
Strategic Collaborations, Certified Solutions, ... [Published Financial Services - Jun 05 2014]
Targos Molecular Pathology GmbH and WuXi Pharma... [Published Financial Services - May 23 2014]
1 2
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.